Policy Developments - Shanghai Municipal Government issued the "Action Plan for Promoting the Full-Chain Development of High-End Medical Device Industry," aiming to approve over 500 domestic Class III medical device registrations and over 100 products for overseas markets by 2027 [1] - The plan also targets the cultivation of two leading enterprises with an annual output value exceeding 10 billion yuan and the establishment of three high-end medical device industrial clusters [1] Drug and Device Approvals - Merck announced that its new non-nucleoside cytomegalovirus (CMV) inhibitor, Letermovir Tablets (II), has been approved by the NMPA in China for preventing CMV infection in adult and pediatric patients undergoing hematopoietic stem cell transplantation [3] - Borui Pharmaceutical received approval from the NMPA to conduct clinical trials for BGM0504 Tablets in overweight/obese adults, which is a dual agonist of GLP-1 and GIP receptors [4] - Kangtai Biological's Sabin strain inactivated poliovirus vaccine (Vero cells) has been approved for market release, enhancing the company's product portfolio [5] Capital Market Activities - Beijing Huakan Biotechnology completed a B+ round financing of several hundred million yuan, attracting multiple leading investment institutions [6][7] - Shanghai Pharmaceuticals' controlling shareholder plans to increase its stake by acquiring 55 million to 74 million H-shares within the next 12 months [8] - Painova Medical successfully completed a B round financing, focusing on the development of high-performance medical devices in neurosurgery [9] Industry Developments - Zhongshan Hospital, in collaboration with Huawei and others, launched the "Meta-Medical Simulation Laboratory" to test AI medical applications [10] - Xisoft Technology announced a strategic acquisition of Yicai Medical Management, aiming to integrate software, data, and consulting services for healthcare institutions [11] - A new type of biohybrid crawling robot has been developed, revealing the connection between neural signals and muscle drive, with potential applications in complex biological systems [12]
上海促进高端医疗器械发展;华龛生物完成数亿元B+轮融资